Balyasny Asset Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
92,852
+60,778
| +189% | +$1.35M | ﹤0.01% | 1155 |
|
|
2025
Q1 | $596K | Buy |
+32,074
| New | +$596K | ﹤0.01% | 1521 |
|
|
2024
Q4 | – | Sell |
-303,211
| Closed | -$10.2M | – | 1896 |
|
|
2024
Q3 | $10.2M | Buy |
+303,211
| New | +$10.2M | 0.02% | 670 |
|
|
2024
Q2 | – | Sell |
-15,746
| Closed | -$355K | – | 1904 |
|
|
2024
Q1 | $355K | Sell |
15,746
-3,202
| -17% | -$72.1K | ﹤0.01% | 1602 |
|
|
2023
Q4 | $406K | Buy |
+18,948
| New | +$406K | ﹤0.01% | 1497 |
|
|
2018
Q4 | – | Sell |
-88,957
| Closed | -$8.88M | – | 1259 |
|
|
2018
Q3 | $8.88M | Buy |
+88,957
| New | +$8.88M | 0.04% | 431 |
|
|
2018
Q2 | – | Sell |
-151,319
| Closed | -$15.7M | – | 1577 |
|
|
2018
Q1 | $15.7M | Buy |
+151,319
| New | +$15.7M | 0.07% | 342 |
|